Efficacy of the Optilume paclitaxel drug-coated balloon after urethroplasty: short-term results from a multicenter study
Background: The Optilume ® paclitaxel drug-coated balloon (DCB) is a relatively new-to-market alternative in the management of male anterior urethral stricture disease. The pivotal trial excluded patients with a history of urethroplasty, although these strictures may be amenable to endoscopic manage...
Saved in:
Main Authors: | Maia VanDyke, Eshan Joshi, Brian Ceballos, Adam Baumgarten, Ethan Matz, Kayla S. Graham, Maxim J. McKibben, Ahmad Imam, Lucas Wiegand, Bryce Franzen, Steven Hudak |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Therapeutic Advances in Urology |
Online Access: | https://doi.org/10.1177/17562872241312522 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of direct visual internal urethrotomy versus balloon dilation to treat recurrent urethral stricture following failed urethroplasty
by: David Gilbert, et al.
Published: (2025-01-01) -
Comparative Analysis Of Continuous And Interrupted Suturing Techniques In Urethroplasty For Hypospadias
by: Kamran Aziz, et al.
Published: (2025-01-01) -
Management of Delayed Onset Postoperative Hemorrhage after Anastomotic Urethroplasty
by: L. A. Bertrand, et al.
Published: (2015-01-01) -
A Prospective Randomized Trial Comparing 2 Different Paclitaxel-Coated Balloons in De Novo Coronary Artery Disease
by: Eun-Seok Shin, MD, PhD, et al.
Published: (2025-01-01) -
Surgical Management of Ischemic Priapism: what are the New Options?
by: Rohit Badia, et al.
Published: (2025-01-01)